PERTINENT TO FRIEDRICH’S ATAXIA: Exenatide, a drug that mimics the effects of the gut hormone GLP-1, increased the levels of frataxin — a protein involved in iron metabolism, whose deficiency leads to Friedreich’s ataxia (FA) — in a mouse model of the disease, a new study shows. Treatment with exanatide also improved the […]
Click here to view original web page at friedreichsataxianews.com
